Trump’s FDA and NIH picks clear committee, teeing up final Senate confirmation
The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...
Fierce Pharma35m
Zevra Therapeutics embarks on diagnosis push as Miplyffa launch gains steam
It’s been just six months since Zevra Therapeutics scored an FD | Niemann-Pick disease type C therapy Miplyffa became ...
Senate panel OKs Makary’s nomination as FDA commissioner
The Senate Committee on Health, Labor and Pensions voted Thursday to approve Marty Makary as commissioner of the Food and Drug Administration. He will likely be confirmed in the full Senate.
STAT1h
Trump’s picks to run FDA and NIH win approval from Senate’s health committee
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
Multiple Sclerosis News Today1h
FDA approves prefilled syringe formulation of Ani’s Cortrophin Gel
The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...
Verywell Health1h
Propranolol vs. Metoprolol: How Do They Compare as Beta-Blockers?
Propranolol and metoprolol are beta-blockers taking to treat certain heart conditions. Learn more about their similarities ...
Clinical Pain Advisor2h
FDA Drug Approval Decisions Expected in April 2025
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.
Dyne: Accelerated Approval Of DYNE-101 Might Be Possible With Surrogate Biomarker
Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.
Newly approved clot-busting drug works as well as traditional drug for stroke, research shows
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a decades-old medication used by most hospitals in the U.S. and could hold ...
Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System
Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
UFlex receives FDA approval for recycled polyethylene in food packaging
The move marks an advancement in reducing plastic waste and assisting global brands in achieving their sustainability ...